FDA Drug Application (201152) for VIRAMUNE XR by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number201152
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVIRAMUNE XR
Active IngredientNEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient NEVIRAPINE17


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM